HPR Dr. Schaffler GmbH führt klinische Studie Phase 1B an Z944 in Zusammenarbeit mit Zalicus durch…

Positive Ergebnisse mit Z944 Phase 1B Schmerz-Studie

Laden Sie die aktuelle Pressemitteilung zur Studie an Z944 herunter oder besuchen Sie unsere englische Seite zu diesem Thema.

About Klaus Schaffler

Dr. med. Klaus Schaffler (MD) has been specializing in the electrophysiology and pharmacology of the human central nervous system (CNS) – as well as in the field of human experimental pain research. During this development process, HPR Dr. Schaffler GmbH has issued over 175 presentations/ publications (sharing more than 50 on pain/ analgesia) and has conducted more than 150 phase-I studies with quite different objectives.
This entry was posted in Klinische Studien. Bookmark the permalink.